Detalhe da pesquisa
1.
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
; 137(4): 513-523, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507295
2.
PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
Br J Cancer
; 127(7): 1352-1364, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794237
3.
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
Oncologist
; 25(6): 523-531, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872928
4.
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
Invest New Drugs
; 38(6): 1755-1762, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328844
5.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
6.
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Curr Treat Options Oncol
; 21(11): 86, 2020 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862320
7.
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
Oncologist
; 24(1): 96-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413668
8.
digit-a tool for detection and identification of genomic interchromosomal translocations.
Nucleic Acids Res
; 45(9): e72, 2017 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28132028
9.
The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
J Biol Chem
; 290(30): 18480-94, 2015 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26085088
10.
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Oncologist
; 21(6): 762-70, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245569
11.
c-Met expression and MET amplification in malignant pleural mesothelioma.
Ann Diagn Pathol
; 23: 1-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402216
12.
Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.
J Hum Genet
; 59(3): 124-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24369359
13.
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer.
Anticancer Drugs
; 24(10): 1079-83, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962904
14.
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
Cancer Cell
; 7(1): 39-49, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15652748
15.
EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma.
Cancers (Basel)
; 15(8)2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190202
16.
PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
Oncogene
; 41(33): 4003-4017, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804016
17.
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.
Front Oncol
; 12: 955440, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052255
18.
Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
Semin Respir Crit Care Med
; 32(1): 78-93, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21500127
19.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Lancet Oncol
; 11(10): 962-72, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20851682
20.
Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges.
Cancers (Basel)
; 14(1)2021 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008273